{
  "ticker": "EW",
  "year": 2024,
  "quarter": 2,
  "last_updated": "2025-04-19T07:36:40.944791",
  "count": 49,
  "transactions": [
    {
      "id": 34262,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-21",
      "transaction_shares": "5625.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "36186.0000"
    },
    {
      "id": 34263,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-11",
      "transaction_shares": "229.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "17081.1980"
    },
    {
      "id": 34268,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-11",
      "transaction_shares": "2854.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76834.9005"
    },
    {
      "id": 34272,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "21.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "184767.8055"
    },
    {
      "id": 34286,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-11",
      "transaction_shares": "985.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "223525.7390"
    },
    {
      "id": 34298,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-11",
      "transaction_shares": "1198.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30561.0000"
    },
    {
      "id": 34299,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-11",
      "transaction_shares": "827.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "76165.4373"
    },
    {
      "id": 34306,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-11",
      "transaction_shares": "821.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "30583.0000"
    },
    {
      "id": 34320,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-11",
      "transaction_shares": "377.0000",
      "transaction_price": "86.7200",
      "transaction_type": "F",
      "shares_after_transaction": "23512.7443"
    },
    {
      "id": 34312,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-10",
      "transaction_shares": "5000.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "52749.7184"
    },
    {
      "id": 34267,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "8158.0000"
    },
    {
      "id": 34284,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 34291,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10773.0000"
    },
    {
      "id": 34294,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "4818.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "73732.0000"
    },
    {
      "id": 34295,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Davis Leslie C.",
      "reporting_owner_cik": "0002021765",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "3055.0000"
    },
    {
      "id": 34314,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "59373.0000"
    },
    {
      "id": 34316,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-08",
      "transaction_shares": "3055.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30035.0000"
    },
    {
      "id": 34266,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-07",
      "transaction_shares": "8725.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "225205.7390"
    },
    {
      "id": 34271,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-07",
      "transaction_shares": "6700.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "48368.7184"
    },
    {
      "id": 34277,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7125.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "184834.8055"
    },
    {
      "id": 34282,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-07",
      "transaction_shares": "33500.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "80335.9005"
    },
    {
      "id": 34304,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-07",
      "transaction_shares": "7000.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31851.0000"
    },
    {
      "id": 34310,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-07",
      "transaction_shares": "4660.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "21575.7443"
    },
    {
      "id": 34311,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2024-05-07",
      "transaction_shares": "3350.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "10648.5547"
    },
    {
      "id": 34313,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-07",
      "transaction_shares": "32025.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "77601.4373"
    },
    {
      "id": 34318,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-07",
      "transaction_shares": "11075.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "32549.0000"
    },
    {
      "id": 34321,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-07",
      "transaction_shares": "2445.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "17488.1980"
    },
    {
      "id": 34264,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "17206.7443"
    },
    {
      "id": 34269,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-05-03",
      "transaction_shares": "634.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "18440.0000"
    },
    {
      "id": 34285,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "43222.4373"
    },
    {
      "id": 34289,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2024-05-03",
      "transaction_shares": "291.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "22459.0000"
    },
    {
      "id": 34290,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-05-03",
      "transaction_shares": "479.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "39288.7184"
    },
    {
      "id": 34297,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2024-05-03",
      "transaction_shares": "527.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "44288.9005"
    },
    {
      "id": 34305,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2024-05-03",
      "transaction_shares": "106.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "15163.1980"
    },
    {
      "id": 34315,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "173811.8055"
    },
    {
      "id": 34319,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2024-05-03",
      "transaction_shares": "395.0000",
      "transaction_price": "85.0600",
      "transaction_type": "F",
      "shares_after_transaction": "213346.7390"
    },
    {
      "id": 34274,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-05-02",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34322,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2024-05-01",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 34288,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-30",
      "transaction_shares": "7250.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26324.0000"
    },
    {
      "id": 19864,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 34309,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, JAPAC",
      "transaction_date": "2024-04-09",
      "transaction_shares": "857.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "18344.7443"
    },
    {
      "id": 19848,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 19855,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 34276,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA",
      "transaction_date": "2024-04-08",
      "transaction_shares": "14400.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "188248.8055"
    },
    {
      "id": 34292,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2024-04-08",
      "transaction_shares": "12500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "52267.7184"
    },
    {
      "id": 19845,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 34270,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-04",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 19863,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    },
    {
      "id": 34308,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2024-04-01",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26329.0000"
    }
  ]
}